Stock Split History
KalVista Pharmaceuticals stock split history picture
KalVista Pharmaceuticals (KALV) has 1 split in our KalVista Pharmaceuticals stock split history database. The split for KALV took place on November 22, 2016. This was a 1 for 14 reverse split, meaning for each 14 shares of KALV owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 71.4285714285714 share position following the split.

When a company such as KalVista Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the KalVista Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 71.4285714285714 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into KalVista Pharmaceuticals shares, starting with a $10,000 purchase of KALV, presented on a split-history-adjusted basis factoring in the complete KalVista Pharmaceuticals stock split history. KalVista Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/10/2015
End date: 03/27/2024
Start price/share: $74.06
End price/share: $11.07
Dividends collected/share: $0.00
Total return: -85.05%
Average Annual Total Return: -19.09%
Starting investment: $10,000.00
Ending investment: $1,495.52
Years: 8.97
KalVista Pharmaceuticals is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. Co. has develop small molecule plasma kallikrein inhibitors targeting the disease hereditary angioedema (HAE). Co. also is conducting preclinical development on an oral Factor XIIa inhibitor program, which Co. is initially improving to provide HAE therapeutics. Co. has developed its candidate sebetralstat into clinical development as a potential oral, on-demand therapy for HAE attacks. Co. also is developing an oral disintegrating tablet formulation of sebetralstat. According to our KalVista Pharmaceuticals stock split history records, KalVista Pharmaceuticals has had 1 split.
Date Ratio
11/22/20161 for 14
KALV is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

KBIO Split History
KIDS Split History
KOOL Split History
KPRX Split History
KRBP Split History
KRON Split History
KRRO Split History
KTRA Split History
KTTA Split History
LABP Split History

Also explore: KALV shares outstanding history

Email EnvelopeFree KALV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

NRx Pharmaceuticals, Inc. (NRXP)
Tritium DCFC Limited (DCFC)
Pluri Inc. (PLUR)
Rent the Runway, Inc. (RENT)
Castor Maritime Inc. (CTRM)
ETAO International Co., Ltd. (ETAO)
Aterian, Inc. (ATER)
Chipotle Mexican Grill, Inc. (CMG)
Moleculin Biotech, Inc. (MBRX)
Longeveron Inc. (LGVN)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »
Funds Holding KalVista Pharmaceuticals
KalVista Pharmaceuticals Insider Buying

KalVista Pharmaceuticals Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.